in immunocompromised patients , intravenous , oral and topical acyclovir shorten the clinical course of herpes simplex infections while prophylaxis with oral or intravenous dosage forms suppresses reactivation of infection during the period of drug administration .
C0001367
acyclovir
C0019348
herpes simplex infections